Terms: = Sarcomas AND JAK2, ENSG00000096968, O60674, JTK10, 3717
89 results:
1. Progression in Myeloid Neoplasms: Beyond the Myeloblast.
Faria C; Tzankov A
Pathobiology; 2024; 91(1):55-75. PubMed ID: 37232015
[TBL] [Abstract] [Full Text] [Related]
2. Resveratrol Loaded by Folate-Modified Liposomes Inhibits Osteosarcoma Growth and Lung Metastasis via Regulating jak2/STAT3 Pathway.
Zhu WT; Zeng XF; Yang H; Jia ML; Zhang W; Liu W; Liu SY
Int J Nanomedicine; 2023; 18():2677-2691. PubMed ID: 37228445
[TBL] [Abstract] [Full Text] [Related]
3. LncRNA KIAA0087 suppresses the progression of osteosarcoma by mediating the SOCS1/jak2/STAT3 signaling pathway.
Gong H; Tao Y; Xiao S; Li X; Fang K; Wen J; He P; Zeng M
Exp Mol Med; 2023 Apr; 55(4):831-843. PubMed ID: 37009803
[TBL] [Abstract] [Full Text] [Related]
4. De novo myeloid sarcoma mimicking gynecological tumors: a retrospective case series of eight patients.
Gu Y; Zheng H; Mo S; Guo T; Chen L; Yang J; Xiang Y
BMC Womens Health; 2023 Mar; 23(1):141. PubMed ID: 36978050
[TBL] [Abstract] [Full Text] [Related]
5. FANCD2 inhibits ferroptosis by regulating the jak2/STAT3 pathway in osteosarcoma.
Li X; Liu J
BMC Cancer; 2023 Feb; 23(1):179. PubMed ID: 36814203
[TBL] [Abstract] [Full Text] [Related]
6. Telocinobufagin inhibits osteosarcoma growth and metastasis by inhibiting the jak2/STAT3 signaling pathway.
Ma X; Xu W; Jin X; Mu H; Wang Z; Hua Y; Cai Z; Zhang T
Eur J Pharmacol; 2023 Mar; 942():175529. PubMed ID: 36690054
[TBL] [Abstract] [Full Text] [Related]
7. Curculigoside Represses the Proliferation and Metastasis of Osteosarcoma via the JAK/STAT and NF-κB Signaling Pathways.
Guo H; Zheng L; Guo Y; Han L; Yu J; Lai F
Biol Pharm Bull; 2022; 45(10):1466-1475. PubMed ID: 36184504
[TBL] [Abstract] [Full Text] [Related]
8. Bisphenol A interacts with DLGAP5 and regulates IL-6/jak2/STAT3 signaling pathway to promote tumorigenesis and progression of osteosarcoma.
Wang Y; Kang J; Wang R; Ramezani K; Bonakdar M; Moghimi N; Salimi M; Yao Y; Wang K
Chemosphere; 2023 Jan; 312(Pt 1):136545. PubMed ID: 36155021
[TBL] [Abstract] [Full Text] [Related]
9. Myeloid Sarcoma of the Breast as Blast Phase of jak2-Mutated (Val617Phe Exon 14p) Essential Thrombocythemia: A Case Report and a Systematic Literature Review.
Pace M; Guadagno E; Russo D; Gencarelli A; Carlea A; Di Spiezio A; Bertuzzi C; Mascolo M; Grimaldi F; Insabato L
Pathobiology; 2023; 90(2):123-130. PubMed ID: 35850113
[TBL] [Abstract] [Full Text] [Related]
10. Pectolinarigenin acts as a potential anti-osteosarcoma agent via mediating SHP-1/jak2/STAT3 signaling.
Zhang T; Li S; Li J; Yin F; Hua Y; Wang Z; Wang H; Zuo D; Xu J; Cai Z
Biomed Pharmacother; 2022 Sep; 153():113323. PubMed ID: 35752008
[TBL] [Abstract] [Full Text] [Related]
11. Quercetin encapsulated in folic acid-modified liposomes is therapeutic against osteosarcoma by non-covalent binding to the JH2 domain of jak2 Via the jak2-STAT3-PDL1.
Jing D; Wu W; Chen X; Xiao H; Zhang Z; Chen F; Zhang Z; Liu J; Shao Z; Pu F
Pharmacol Res; 2022 Aug; 182():106287. PubMed ID: 35671921
[TBL] [Abstract] [Full Text] [Related]
12. Circ_0016347 modulates proliferation, migration, invasion, cell cycle, and apoptosis of osteosarcoma cells
Liu Y; Yuan J; Zhang Q; Ren Z; Li G; Tian R
Autoimmunity; 2022 Jun; 55(4):264-274. PubMed ID: 35166635
[TBL] [Abstract] [Full Text] [Related]
13. Asiatic Acid Induces Mitochondrial Apoptosis via Inhibition of jak2/STAT3 Signalling Pathway in Human Osteosarcoma.
Yan BF; Chen X; Liu J; Liu SJ; Zhang JZ; Zeng QQ; Duan JA
Folia Biol (Praha); 2021; 67(3):108-117. PubMed ID: 35151244
[TBL] [Abstract] [Full Text] [Related]
14. Liensinine Inhibits Osteosarcoma Growth by ROS-Mediated Suppression of the jak2/STAT3 Signaling Pathway.
Jia F; Liu Y; Dou X; Du C; Mao T; Liu X
Oxid Med Cell Longev; 2022; 2022():8245614. PubMed ID: 35116094
[TBL] [Abstract] [Full Text] [Related]
15. Hypoxia inducible factor-3α promotes osteosarcoma progression by activating KDM3A-mediated demethylation of SOX9.
Li ZF; Meng DD; Liu YY; Bi FG; Tian K; Xu JZ; Sun JG; Gu CX; Li Y
Chem Biol Interact; 2022 Jan; 351():109759. PubMed ID: 34826399
[TBL] [Abstract] [Full Text] [Related]
16. FAT10 stimulates the development of osteosarcoma by regulating the JAK/STAT signaling pathway.
Shi F; Li L; Cheng Y
J BUON; 2021; 26(5):2090-2096. PubMed ID: 34761621
[TBL] [Abstract] [Full Text] [Related]
17. THAP9-AS1 Promotes Tumorigenesis and Reduces ROS Generation through the jak2/STAT3 Signaling Pathway by Increasing SOCS3 Promoter Methylation in Osteosarcoma.
Yang S; Wang B; Liu C; Wang Q; Wang R; Su W; Zhu Y; Li M; Guo Z; Wu X; Chen F
Oxid Med Cell Longev; 2021; 2021():5620475. PubMed ID: 34691358
[TBL] [Abstract] [Full Text] [Related]
18. miRNA-221-3p derived from M2-polarized tumor-associated macrophage exosomes aggravates the growth and metastasis of osteosarcoma through SOCS3/jak2/STAT3 axis.
Liu W; Long Q; Zhang W; Zeng D; Hu B; Liu S; Chen L
Aging (Albany NY); 2021 Aug; 13(15):19760-19775. PubMed ID: 34388111
[TBL] [Abstract] [Full Text] [Related]
19. Myeloid/lymphoid neoplasms with FLT3 rearrangement.
Tang G; Tam W; Short NJ; Bose P; Wu D; Hurwitz SN; Bagg A; Rogers HJ; Hsi ED; Quesada AE; Wang W; Miranda RN; Bueso-Ramos CE; Medeiros LJ; Nardi V; Hasserjian RP; Arber DA; Orazi A; Foucar K; Wang SA
Mod Pathol; 2021 Sep; 34(9):1673-1685. PubMed ID: 33990705
[TBL] [Abstract] [Full Text] [Related]
20. Piperlongumine inhibits the progression of osteosarcoma by downregulating the SOCS3/jak2/STAT3 pathway via miR-30d-5p.
Hu Y; Luo X; Zhou J; Chen S; Gong M; Deng Y; Zhang H
Life Sci; 2021 Jul; 277():119501. PubMed ID: 33862108
[TBL] [Abstract] [Full Text] [Related]
[Next]
